News & Event Videos

A new study on a gene called VPS13C adds to growing evidence that lysosomal dysfunction may be one mechanism through which Parkinson’s disease arises.

New findings reveal motor and cognitive deficits arise through separate mechanisms in Parkinson’s disease, challenging previous thinking.

Yale School of Medicine teams have received three grants totaling $18 million from Aligning Science Across Parkinson’s (ASAP), a coordinated research initiative devoted to accelerating the pace of discovery and informing the path to a cure for Parkinson’s disease (PD) research.

Our new research center at Yale has surged forward on multiple fronts: new drug discovery via AI, powerful biomarker studies, and a thriving clinical program.

"Dementia is often the scariest thing for many patients with Parkinson's disease, more so than motor symptoms," says Sreeganga Chandra, PhD, professor of neurology and of neuroscience at Yale School of Medicine (YSM) and the study's principal investigator. "We are trying to understand the basis of cognitive dysfunction and whether we can find targets to ameliorate it."

The Yale Legacy Tissue donation program has provided over 1,500 tissue samples to Yale researchers since its creation in 2022.

A Yale study finds specialized immune cells in the brains of mice and humans in the absence of disease, questioning previous dogma about interactions between the brain and the immune system.

Longevity experts see fighting chronic inflammation as key to healthier aging. Dr. David Hafler discusses inflammation as a "double-edge sword."

The YSM Community is invited to join a dean's workshop introducing our new inter-departmental Stephen & Denise Adams Center for Parkinson’s Disease Research led by founding Director Clemens Scherzer, MD. The session, titled "Building the Future of Precision Neurology," will be held on Thursday, March 27, from 1 to 5 p.m.